Apostolia M Tsimberidou1, Razelle Kurzrock2. 1. Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: atsimber@mdanderson.org. 2. Center for Personalized Cancer Therapy, and Division of Hematology and Oncology, UCSD Moores Cancer Center, La Jolla, CA, USA.
Authors: Apostolia-Maria Tsimberidou; David S Hong; Yang Ye; Carrie Cartwright; Jennifer J Wheler; Gerald S Falchook; Aung Naing; Siqing Fu; Sarina Piha-Paul; Filip Janku; Funda Meric-Bernstam; Patrick Hwu; Bryan Kee; Merrill S Kies; Russell Broaddus; John Mendelsohn; Kenneth R Hess; Razelle Kurzrock Journal: JCO Precis Oncol Date: 2017-09-08
Authors: Michael A Thompson; Jennifer J Godden; Deborah Wham; Antony Ruggeri; Michael P Mullane; Amanda Wilson; Shamsuddin Virani; Scott M Weissman; Brenda Ramczyk; Pamela Vanderwall; James L Weese Journal: J Patient Cent Res Rev Date: 2019-01-28
Authors: Pushpinder Kaur; Tania B Porras; Anthony Colombo; Alexander Ring; Janice Lu; Irene Kang; Julie E Lang Journal: Br J Cancer Date: 2021-08-28 Impact factor: 9.075
Authors: Derrick S Haslem; Ingo Chakravarty; Gail Fulde; Heather Gilbert; Brian P Tudor; Karen Lin; James M Ford; Lincoln D Nadauld Journal: Oncotarget Date: 2018-02-02